Team Internet Group PLC earlier this week outlined progress on its strategic transformation, debt reduction, and product focus during the first half of 2025.
Chief executive Michael Riedl told Proactive that the company had modernised its product portfolio, expanded into new geographies, and streamlined its cost base. These changes, he said, contributed to a more balanced and resilient business.
Global digital asset exchange-traded products (ETPs) ended August 2025 with $205.23 billion in assets under management (AUM), marking the second consecutive month above the $200 billion threshold, an analysis from Fineqia International Inc (CSE:FNQ, OTC:FNQQF) has shown.
In its report, Fineqia said that this total represented a 1.3% decline from July’s record high of $207.82 billion.
Nano One Materials Corp (TSX:NANO, OTC:NNOMF) announced an equity distribution agreement with Canaccord Genuity Corp and Roth Canada to establish an at-the-market (ATM) equity issuance program that may distribute up to C$15 million worth of Nano One Materials common shares from time to time.
The process technology company specializing in lithium-ion battery cathode active materials said it currently intends to use the net proceeds, if any, to fund ongoing operations.
GoviEx Uranium Inc (TSX-V:GXU, OTCQB:GVXXF) announced that securityholders representing more than 40% of its outstanding securities have entered into binding voting support agreements in favor of its planned reverse takeover of Tombador Iron.
The transaction would create Atomic Eagle, an ASX-listed uranium developer that GoviEx said will have a strengthened balance sheet and a mandate to advance the Muntanga project in Zambia.
Alvopetro Energy Ltd (TSX-V:ALV, OTC:ALVOF) reported August sales volumes of 2,375 barrels of oil equivalent per day (boepd), based on field estimates.
The natural gas producer said August sales volumes in Brazil averaged 2,257 boepd, including natural gas sales of 12.7 million cubic feet per day (MMcfpd), associated natural gas liquids sales from condensate of 132 bopd and oil sales of 9 bopd.
Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF)'s Sam Lanyon earlier this week discussed with Proactive two material developments in its diagnostics pipeline. The company has signed a US$1.5 million contract with Aptatek Biosciences Inc. to progress development of the PheCheck™ PKU monitoring device, and separately secured new BARDA funding to support a paediatric trial of its FebriDx® rapid test.
Race Oncology Ltd (ASX:RAC, OTC:RAONF) earlier this week announced the activation of its first clinical site in Hong Kong for the Phase 1 trial of RC220 in combination with doxorubicin. The site, located at Queen Mary Hospital, enables the start of patient enrolment in the region. The company said screening is underway and the first patient is expected to begin treatment this month. CEO Dr Daniel Tillett told Proactive, the activation of the first trial site in Hong Kong marks a key development for the company. “We appreciate the dedication of the investigators, clinical teams and patients participating in the trial. We look forward to the first patient being treated in Hong Kong,” he said.
